May 4 - 5, 2026  15–19, 2026 | Congress Center Basel | Basel, Switzerland

StageBio is excited to attend Swiss Biotech Day 2026 in Basel, Switzerland this May. Our team will be on-site and ready to connect with you to discuss how we can support your drug development programs. Whether you're advancing early discovery, IND-enabling studies, or late-stage development, we're here to explore how our scientific expertise and comprehensive pathology services can help drive your programs forward.

Swiss Biotech Day has grown into one of the premier global biotechnology conferences for life sciences professionals, bringing together more than 3,000 senior experts from across the industry to network, exchange ideas, and explore advances in R&D, manufacturing, and innovative partnerships. Come find our team and learn how StageBio's collaborative approach to histopathology delivers the precision, quality, and regulatory confidence sponsors need to bring safe and effective therapies to market.

StageBio's Expertise in Preclinical Pathology

StageBio provides comprehensive pathology services to support drug and medical device development programs at every stage. Our capabilities include:

• Toxicologic Pathology: Significant experience in both GLP and non-GLP studies across all major species, with expertise in reporting, study design, and peer review to support IND-enabling and late-stage development programs.

• Pathology Expertise: 20+ pathologists working across sites, providing specialized expertise in organ systems such as the nervous, immune, and ocular systems, and therapeutic modalities including biologics, cell and gene therapy, immuno-oncology, and medical devices. Deliverables include reports, peer reviews, consulting, and tailored support for complex client needs.

• Specialized Histology Expertise: High-quality, reproducible histology supported by advanced capabilities including IHC/IF assay development, custom biomarker validation, plastic embedding for hard tissues and medical devices, and precision histotechnology workflows designed for complex studies.

Whether you're developing a small molecule, biologic, gene therapy, or medical device, StageBio's team brings the proven expertise and regulatory insight needed to advance your program with confidence.

Meet Our Team

Garek Wilashko  Business Development Director Garek Wilashko serves as a strategic partner for drug developers navigating the histopathology phase of their preclinical programs. He works to connect clients with the right scientific experts, help shape study designs aligned to program goals, and ensure all critical pieces are in place for projects to move forward efficiently. His focus is on helping sponsors avoid common missteps, identify tailored solutions, and obtain the clarity and precision their tissue-based studies require.

Connect With Us

Find us at Swiss Biotech Day 2026 to discuss your pathology needs, explore partnership opportunities, or simply connect with our team. We look forward to seeing you in Basel!

For more information about StageBio's preclinical pathology services, reach out to us.

Register for Swiss Biotech Day 2026!